Address
NGN Capital LLC
369 Lexington Avenue
17th Floor
New York, NY 10017
United States
Phone
Email
Website
Recent investment activity
KANDO id: 24094
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 32Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Artesian Therapeutics Inc | N/A | |||||
BeneChill Inc | N/A | |||||
Bioarray Solutions Ltd | N/A | |||||
Cerapedics Inc | Series B | |||||
Ekos Corp | Series C | |||||
Ekos Corp | Series B | |||||
Exosome Diagnostics Inc | N/A | |||||
Horizon Pharma USA Inc | N/A | |||||
Javelin Pharmaceuticals Inc | N/A | |||||
Jerini | Developer of a unique proprietary drug discovery platform. | N/A | ||||
KIKA Medical International Co | N/A | |||||
Medrium Inc | N/A | |||||
Micromet Inc | Designs and develops innovative antibody based drugs for the treatment of cancer, autoimmune and inflammatory diseases | N/A | ||||
MultiPlan Inc | Leading provider of healthcare cost management solutions and transaction-based services to insurers, health plan administrators, and other payers of h | N/A | ||||
NANIRX Therapeutics Inc | N/A | |||||
Noxxon Pharma AG | Mirror image oligonucleotide drugs. | N/A | ||||
OptiScan Biomedical Corp | N/A | |||||
Power Medical Interventions Inc | Medical device manufacturer, designs, manufactures, and markets the SurgASSIST platform of Intelligent Surgical Instruments | N/A | ||||
Resverlogix Corp | N/A | |||||
Santhera Pharmaceuticals AG | Small molecule therapeutics for neuromuscular and metabolic diseases. IPO in November 2006. | N/A | ||||
Sightline Technologies | N/A | |||||
Small Bone Innovations Inc | N/A | |||||
Spine View Inc | N/A | |||||
Tigris Pharmaceuticals Inc | N/A | |||||
Valtech Cardio Ltd | N/A |